Clinical Judgment: Optimal Care vs Selection Bias in Oncology: Episode 2
Website: https://www.onclive.comTwitter: https://twitter.com/OncLiveFacebook: https://www.facebook.com/OncLive/LinkedIn: https://www.linkedin.com/company/onc…
Related Articles
SUPRAME Trial Seeks to Establish IMA203 as the First TCR-Based Therapy for Cutaneous Melanoma
The phase 3 SUPRAME trial is comparing IMA203 vs investigator’s choice of therapy in patients with pretreated unresectable or metastatic cutaneous melanoma.
The Cloud Reset Revolution: Why 70% of Companies Are Leaving Public Cloud Behind
The Broadcom Private Cloud Outlook 2025 report uncovers a pivotal shift in enterprise cloud strategies, revealing a “cloud reset” as organizations recalibrat…
Updated EHA-EMN Guidelines Include Melphalan Flufenamide for R/R Myeloma
The EHA-EMN guidelines now include melphalan flufenamide for certain patients with relapsed/refractory multiple myeloma.
Nogapendekin Alfa Inbakicept Plus BCG Approved in UK for BCG-Unresponsive NMIBC With CIS
The combination of nogapendekin alfa inbakicept and BCG is now approved in the United Kingdom for the treatment of patients with NMIBC with CIS.
Five Under 5: Top Oncology Videos for the Week of 7/27
The top 5 OncLive videos of the week cover insights in lung cancer, myelofibrosis, and mantle cell lymphoma.
FDA Approves Oncomine Dx Express Test for Tumor Profiling and as Companion Diagnostic for Sunvozertinib in NSCLC
The FDA approved the Oncomine Dx Express Test for tumor profiling and as a companion diagnostic for sunvozertinib in non–small cell lung cancer.
Real-World Analysis Sheds Light on Fruquintinib Use in Later-Line Metastatic CRC
A real-world study in Portugal showed fruquintinib displayed a manageable safety profile and an efficacy trend in refractory colorectal cancer.
FDA Approves Y-90 Resin Microspheres for Unresectable HCC
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
EULAR 2025 – Interview with Prof. Daniel Aletaha
🎥 Watch this interview with Prof. Daniel Aletaha, right after the EULAR 2025 Opening Plenary!He reflects on his presidency, shares thoughts on the new myEUL…
